Suppr超能文献

对肌萎缩侧索硬化症/额颞叶痴呆(ALS/FTD)患者和癌症患者中报告的TBK1错义突变的功能丧失分析

Frustration analysis of TBK1 missense mutations reported in ALS/FTD and cancer patients.

作者信息

Khatoon Fatima, Kumar Vijay, Anjum Farah, Shafie Alaa, Adnan Mohd, Hassan Md Imtaiyaz

机构信息

Amity Institute of Neuropsychology and Neurosciences, Amity University, Noida, Uttar Pradesh 201303 India.

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.

出版信息

3 Biotech. 2022 Aug;12(8):174. doi: 10.1007/s13205-022-03240-0. Epub 2022 Jul 14.

Abstract

UNLABELLED

Tank-binding kinase 1 (TBK1) is a multifunctional kinase having essential roles in cellular processes, autophagy/mitophagy, and selective clearance of damaged proteins. More than 90 mutations in the gene are linked with multiple cancer types, amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD). Some of these missense mutations disrupt the abilities of TBK1 to dimerize, associate with the mitophagy receptor optineurin (OPTN), autoactivate, or catalyze phosphorylation. Some mutations may cause severe dysregulation of the pathway, while others induce a limited disruption. Here, we have studied those mutations reported in cancer, ALS and FTD, and subsequently investigated the effect of missense mutations on the structure and function of TBK1 for localized residual frustration change. Out of 33 ALS/FTD causing mutations and 28 oncogenic mutations, 10 mutations and 12 oncogenic mutations showed significant change in the residual frustration. The local frustration plays an important role in the conformation of protein structure in active and inactive kinases. Our analysis reports the change in residual frustration state, conformational change and effect on active and inactive TBK1 function due to ALS/FTD causing and oncogenic missense mutations.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13205-022-03240-0.

摘要

未标记

Tank结合激酶1(TBK1)是一种多功能激酶,在细胞过程、自噬/线粒体自噬以及受损蛋白质的选择性清除中起重要作用。该基因中的90多个突变与多种癌症类型、肌萎缩侧索硬化症(ALS)和额颞叶痴呆(FTD)有关。其中一些错义突变破坏了TBK1二聚化、与线粒体自噬受体视紫质(OPTN)结合、自激活或催化磷酸化的能力。一些突变可能导致该途径的严重失调,而其他突变则引起有限的破坏。在这里,我们研究了在癌症、ALS和FTD中报道的那些突变,随后研究了错义突变对TBK1结构和功能的影响,以了解局部残余挫折变化。在33个导致ALS/FTD的突变和28个致癌突变中,10个突变和12个致癌突变在残余挫折方面显示出显著变化。局部挫折在活性和非活性激酶的蛋白质结构构象中起重要作用。我们的分析报告了由于导致ALS/FTD的错义突变和致癌错义突变引起的残余挫折状态变化、构象变化以及对活性和非活性TBK1功能的影响。

补充信息

在线版本包含可在10.1007/s13205-022-03240-0获取的补充材料。

相似文献

本文引用的文献

9
Targeting TANK-binding kinase 1 (TBK1) in cancer.针对癌症中的 TANK 结合激酶 1(TBK1)。
Expert Opin Ther Targets. 2020 Nov;24(11):1065-1078. doi: 10.1080/14728222.2020.1826929. Epub 2020 Oct 5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验